These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17891137)

  • 21. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
    Poulikakos PI; Xiao GH; Gallagher R; Jablonski S; Jhanwar SC; Testa JR
    Oncogene; 2006 Sep; 25(44):5960-8. PubMed ID: 16652148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
    Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase.
    Jin H; Sperka T; Herrlich P; Morrison H
    Nature; 2006 Aug; 442(7102):576-9. PubMed ID: 16885985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
    Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
    Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation.
    Huang J; Chen J
    Oncogene; 2008 Jul; 27(29):4056-64. PubMed ID: 18332868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional inactivation of NF2/merlin in human mesothelioma.
    Thurneysen C; Opitz I; Kurtz S; Weder W; Stahel RA; Felley-Bosco E
    Lung Cancer; 2009 May; 64(2):140-7. PubMed ID: 18835652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of Merlin by Aurora A kinase appears necessary for mitotic progression.
    Mandati V; Del Maestro L; Dingli F; Lombard B; Loew D; Molinie N; Romero S; Bouvard D; Louvard D; Gautreau AM; Pasmant E; Lallemand D
    J Biol Chem; 2019 Aug; 294(35):12992-13005. PubMed ID: 31296571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
    Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
    BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.
    Tokuda E; Fujita N; Oh-hara T; Sato S; Kurata A; Katayama R; Itoh T; Takenawa T; Miyazono K; Tsuruo T
    Cancer Res; 2007 Oct; 67(20):9666-76. PubMed ID: 17942896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cigarette smoke-induced alterations in endothelial nitric oxide synthase phosphorylation: role of protein kinase C.
    Wagner L; Laczy B; Tamaskó M; Mazák I; Markó L; Molnár GA; Wagner Z; Mohás M; Cseh J; Fekete A; Wittmann I
    Endothelium; 2007; 14(4-5):245-55. PubMed ID: 17922342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation.
    Wei Y; Yee PP; Liu Z; Zhang L; Guo H; Zheng H; Anderson B; Gulley M; Li W
    EMBO Rep; 2020 Dec; 21(12):e50642. PubMed ID: 33058421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding.
    Thaxton C; Lopera J; Bott M; Baldwin ME; Kalidas P; Fernandez-Valle C
    Mol Cell Neurosci; 2007 Feb; 34(2):231-42. PubMed ID: 17175165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
    Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
    Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tumour suppressor protein NF2/merlin: the puzzle continues.
    Hovens CM; Kaye AH
    J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
    Sato T; Sekido Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raptor-rictor axis in TGFbeta-induced protein synthesis.
    Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
    Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of merlin by protein phosphatase 1-TIMAP and EBP50 in endothelial cells.
    Boratkó A; Péter M; Csortos C
    Int J Biochem Cell Biol; 2017 Jan; 82():10-17. PubMed ID: 27871951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.
    Laulajainen M; Muranen T; Nyman TA; Carpén O; Grönholm M
    Neoplasia; 2011 Jul; 13(7):643-52. PubMed ID: 21750658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Src-p38 mitogen-activated protein kinase signaling is required for Akt activation in response to ionizing radiation.
    Kim MJ; Byun JY; Yun CH; Park IC; Lee KH; Lee SJ
    Mol Cancer Res; 2008 Dec; 6(12):1872-80. PubMed ID: 19074832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.